Session
Clinical proteomics: from discovery to validation

Program

• 15:15 – 15:40 20 Min. 5 Min.

  • Keynote lecture

  Opportunities and challenges in clinical proteomics: from tissue discovery to plasma validation

  • Manuel Mayr (London / GB)
• 15:40 – 15:52 10 Min. 2 Min.

  • Oral presentation
  • OP-13

  Absolute quantification of the synaptic blood marker β-synuclein by targeted mass spectrometry ranks synaptic degeneration after amyloid deposition in autosomal dominant Alzheimer's disease

  • Patrick Oeckl (Ulm / DE)

   Clinical Proteomics
• 15:52 – 16:04 10 Min. 2 Min.

  • Oral presentation
  • OP-14

  Identification of novel diagnostic protein biomarkers in human plasma for breast cancer by targeted protein assay

  • Kristrun Yr Holm (Garður / IS)

   Clinical Proteomics
• 16:04 – 16:16 10 Min. 2 Min.

  • Oral presentation
  • OP-15

  Preoperative diagnosis of thyroid nodules using a multi-omics test

  • Xue Cai (Hangzhou / CN)

   Clinical Proteomics